This DMPA-SC Advocacy Pack brief offers quick facts on the benefits of DMPA-SC; the product’s potential for empowering women and adolescent girls; the product’s availability; and how subcutaneous DMPA is different from intramuscular DMPA (DMPA-IM).

This DMPA-SC Advocacy Pack brief details the strong body of evidence and experience with self-injection of DMPA-SC, including how the practice can reduce access-related barriers, improve contraceptive continuation, and enhance women’s autonomy.

This DMPA-SC Advocacy Pack brief provides examples of actions that may be useful for advocates seeking to increase access to DMPA-SC, including self-injection.

This customizable DMPA-SC Advocacy Pack template provides a brief description of DMPA-SC; an overview of evidence on how the product expands access through multiple delivery channels; and policy and advocacy recommendations for country decision-makers.

This customizable slide deck template from the DMPA-SC Advocacy Pack provides a brief description of DMPA-SC and its benefits; an overview of evidence on how the product expands access through multiple delivery channels; and illustrative policy and advocacy gaps and recommendations for country decision-makers. Available in PowerPoint and PDF formats.

This DMPA-SC Advocacy Pack template includes a framework that supports individuals and organizations to develop a high-impact, outcome-oriented policy advocacy strategy. The template is available as a Word file in order to be customized for your context.

This DMPA-SC Advocacy Pack brief helps you understand the terms surrounding DMPA injectables to inform your messaging and communication.

This DMPA-SC Advocacy Pack brief packages accurate, evidence-based messages about the features and benefits of DMPA-SC and how the product can increase women’s access to contraception.

This DMPA-SC Advocacy Pack brief describes key evidence-building efforts, advocacy actions, and policy changes in Uganda brought about by key partners to increase access to injectable contraception, including DMPA-SC. You can draw on lessons learned from Uganda to inform your policy goals and advocacy strategy for increasing method choice and access with DMPA-SC and self-injection in your country.

This DMPA-SC Advocacy Pack brief summarizes important takeaways for advocates based on World Health Organization guidance on hormonal contraception, including DMPA injectables, and HIV for women at high risk of HIV.